Efficacy of the Omnipod® 6 System Compared With the Omnipod® 5 System
NCT07579702
This study is recruiting at 11 US sites in 10 states, according to its ClinicalTrials.gov record last updated .
Summary
This multi-center, randomized, cross-over trial will evaluate the efficacy of the Omnipod 6 System compared with the Omnipod 5 System in individuals with type 1 or type 2 diabetes and suboptimal glycemia.
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- Type 2 Diabetes Mellitus
- Type 1 Diabetes Mellitus
Eligibility basics and study details
- Study type
- Interventional
- Phase
- Not applicable
- Ages
- 14 to 75 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Sponsor
- Insulet Corporation
- Last updated on ClinicalTrials.gov
- August 3, 2026
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
California · 2
- University of Southern California · Los Angeles, CA
- Sansum Diabetes Research Institute · Santa Barbara, CA
Colorado · 1
- University of Colorado · Aurora, CO
Connecticut · 1
- Yale · New Haven, CT
Georgia · 1
- Emory University · Atlanta, GA
Illinois · 1
- Northwestern University · Chicago, IL
Indiana · 1
- Indiana University · Indianapolis, IN
Massachusetts · 1
- Joslin Diabetes Center · Boston, MA
Michigan · 1
- Henry Ford Health Systems · Detroit, MI
Minnesota · 1
- Health Partners · Minneapolis, MN
Texas · 1
- Baylor College of Medicine · Houston, TX
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.